Modalis Therapeutics Corp
TSE:4883
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Modalis Therapeutics Corp
TSE:4883
|
JP |
|
One REIT Inc
TSE:3290
|
JP |
|
Gunze Ltd
TSE:3002
|
JP |
|
M
|
Mediclin AG
XBER:MED
|
DE |
|
Yutong Bus Co Ltd
SSE:600066
|
CN |
|
C
|
Creative Technology Ltd
OTC:CREAF
|
SG |
|
A
|
AGES Industri AB
STO:AGES B
|
SE |
|
S
|
Saigon Hanoi Securities JSC
VN:SHS
|
VN |
|
Darling Ingredients Inc
NYSE:DAR
|
US |
|
V
|
V-mart Retail Ltd
BSE:534976
|
IN |
Cash Flow Statement
Cash Flow Statement
Modalis Therapeutics Corp
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(745)
|
(1 547)
|
(2 707)
|
(2 959)
|
(2 391)
|
(2 138)
|
(1 317)
|
(1 556)
|
(2 151)
|
|
| Depreciation & Amortization |
78
|
100
|
124
|
66
|
1
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
6
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(487)
|
(525)
|
678
|
754
|
41
|
(45)
|
(21)
|
92
|
35
|
|
| Cash Taxes Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash Interest Paid |
0
|
4
|
6
|
5
|
4
|
4
|
4
|
3
|
3
|
|
| Change in Working Capital |
407
|
493
|
10
|
(23)
|
94
|
(23)
|
(94)
|
54
|
(2)
|
|
| Cash from Operating Activities |
(747)
N/A
|
(1 479)
-98%
|
(1 896)
-28%
|
(2 162)
-14%
|
(2 254)
-4%
|
(2 207)
+2%
|
(1 432)
+35%
|
(1 411)
+1%
|
(2 118)
-50%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(107)
|
(231)
|
(197)
|
(105)
|
(40)
|
(2)
|
(0)
|
(1)
|
(3)
|
|
| Other Items |
279
|
9
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
172
N/A
|
(222)
N/A
|
(186)
+17%
|
(105)
+44%
|
(40)
+62%
|
(2)
+95%
|
(0)
+91%
|
(1)
-210%
|
(3)
-341%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
73
|
24
|
71
|
682
|
741
|
383
|
2 396
|
2 798
|
1 367
|
|
| Net Issuance of Debt |
0
|
(4)
|
(7)
|
(6)
|
482
|
481
|
649
|
649
|
(16)
|
|
| Other |
(0)
|
(0)
|
(1)
|
(1)
|
(7)
|
(7)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
73
N/A
|
20
-73%
|
64
+221%
|
675
+960%
|
1 216
+80%
|
858
-30%
|
3 045
+255%
|
3 447
+13%
|
1 351
-61%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
18
|
56
|
15
|
24
|
28
|
38
|
79
|
(52)
|
7
|
|
| Net Change in Cash |
(485)
N/A
|
(1 626)
-235%
|
(2 003)
-23%
|
(1 567)
+22%
|
(1 050)
+33%
|
(1 313)
-25%
|
1 692
N/A
|
1 983
+17%
|
(763)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(855)
N/A
|
(1 710)
-100%
|
(2 093)
-22%
|
(2 267)
-8%
|
(2 294)
-1%
|
(2 209)
+4%
|
(1 432)
+35%
|
(1 411)
+1%
|
(2 121)
-50%
|
|